3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
26
Prostatic Neoplasms
5
Osteosarcoma
5
Neuroendocrine Tumors
5
Neoplasms
5
Kidney Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Neoplasm Metastasis
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma, Ewing
3
Sarcoma
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Medullary
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Small Cell Lung Carcinoma
2
Penile Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
tazemetostat
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Topotecan
2
Methotrexate
2
LY3023414
2
Etoposide
2
Cisplatin
2
Carboplatin
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
cabozantinib
×
90 days
×
Clear all
No trials found.